Launch of the NFG027 Junior Research Group
Currently available therapies are mostly designed for the "average" patient and neglect patient-to-patient heterogeneity. The aim of the project is to use artificial intelligence approaches, which are already changing the professional world in many ways, to discover previously unknown molecular signatures and to unlock their biomarker potential for personalized medicine.
Read more